Loading insider details...
Beta
Latest Form 4 (Jan 6, 2026): Grant/Award of 155 REGN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 6, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 155 | n/a |
| Jan 6, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 166 | n/a |
| Jun 7, 2024 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/Award | 10,290 | n/a |
| Jun 5, 2024 | Cerevel Therapeutics Holdings, Inc. (CERE) | Exercise/Conversion | 50,000 | $175.0K |
| May 14, 2024 | Cerevel Therapeutics Holdings, Inc. (CERE) | Exercise/Conversion | 50,000 | $175.0K |
| Apr 3, 2024 | Cerevel Therapeutics Holdings, Inc. (CERE) | Exercise/Conversion | 50,000 | $175.0K |
| Mar 6, 2024 | Cerevel Therapeutics Holdings, Inc. (CERE) | Exercise/Conversion | 50,000 | $175.0K |
| Mar 4, 2024 | Cerevel Therapeutics Holdings, Inc. (CERE) | Exercise/Conversion | 50,000 | $175.0K |
| Feb 8, 2024 | Cerevel Therapeutics Holdings, Inc. (CERE) | Exercise/Conversion | 15,440 | n/a |
| Jan 4, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 135 | n/a |